US Stock MarketDetailed Quotes

DRUG Bright Minds Biosciences

Watchlist
  • 1.0950
  • -0.1150-9.50%
Trading Aug 28 13:54 ET
4.89MMarket Cap-1671P/E (TTM)

Bright Minds Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
114.55%240.16K
46.77%-805.09K
69.14%-822.09K
48.30%-7.02M
43.74%-1.2M
42.33%-1.65M
58.51%-1.51M
46.20%-2.66M
-85.63%-13.59M
10.92%-2.13M
Net income from continuing operations
115.77%229.9K
72.00%-574.14K
27.88%-1.68M
50.74%-7.37M
48.40%-1.53M
45.14%-1.46M
54.31%-2.05M
51.93%-2.34M
-72.99%-14.96M
-3.28%-2.96M
Operating gains losses
69.64%-39.61K
-59.39%2.17K
500.01%42.3K
117.52%45.35K
417.62%163.44K
-467.93%-130.47K
-23.72%5.33K
103.68%7.05K
-15.66%-258.82K
66.21%-51.46K
Depreciation and amortization
0.00%18.11K
-0.01%18.11K
0.01%18.11K
1,100.10%72.45K
200.02%18.11K
--18.11K
--18.11K
--18.11K
--6.04K
--6.04K
Other non cash items
-72.88%1.24K
-60.14%2.13K
-50.93%2.97K
-32.88%19.75K
74.23%3.79K
--4.58K
--5.33K
--6.06K
-92.02%29.42K
--2.17K
Change In working capital
52.35%-153.43K
-200.16%-479.99K
168.74%579.85K
-230.05%-941.72K
-130.26%-255.36K
35.77%-322K
-11.94%479.25K
-419.24%-843.6K
136.58%724.13K
233.34%843.75K
-Change in receivables
862.32%536.01K
-2,061.29%-508.21K
-108.35%-8.06K
360.33%118.8K
173.02%66.7K
-162.80%-70.31K
197.00%25.91K
344.04%96.5K
58.57%-45.63K
-184.01%-91.34K
-Change in prepaid assets
-215.89%-43K
181.02%16.76K
-169.82%-4.38K
3,519.30%136.74K
235.54%114.04K
662.24%37.11K
-136.29%-20.68K
-75.93%6.27K
104.20%3.78K
-109.65%-84.14K
-Change in payables and accrued expense
-123.84%-646.44K
-97.58%11.46K
162.58%592.29K
-256.30%-1.2M
-142.79%-436.1K
53.28%-288.8K
-7.76%474.02K
-535.25%-946.38K
51.34%765.99K
213.21%1.02M
Cash from discontinued investing activities
Operating cash flow
114.55%240.16K
46.77%-805.09K
69.14%-822.09K
48.30%-7.02M
43.74%-1.2M
42.33%-1.65M
58.51%-1.51M
46.20%-2.66M
-85.63%-13.59M
10.92%-2.13M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-2.18%-21.96K
-2.17%-21.96K
-61.05%878.04K
-57.86%2.19M
-100.43%-21.65K
-279.08%-21.49K
-1,376.13%-21.49K
1,806.39%2.25M
-80.06%5.2M
52,308.82%5.06M
Net issuance payments of debt
-2.18%-21.96K
-2.17%-21.96K
-2.18%-21.96K
-1,102.35%-86.11K
-187.14%-21.65K
---21.49K
32.84%-21.49K
---21.49K
---7.16K
--24.84K
Net common stock issuance
--0
--0
-26.08%900K
-69.83%1.22M
--0
--0
--0
--1.22M
-85.46%4.03M
--4.03M
Proceeds from stock option exercised by employees
--0
--0
--0
-44.87%1.09M
--0
--0
--0
817.78%1.09M
1,576.70%1.97M
19,050.48%1.84M
Net other financing activities
----
----
----
96.63%-26.98K
--0
--0
--0
---26.98K
55.72%-799.98K
---833.66K
Cash from discontinued financing activities
Financing cash flow
-2.18%-21.96K
-2.17%-21.96K
-61.05%878.04K
-57.86%2.19M
-100.43%-21.65K
-279.08%-21.49K
-1,376.13%-21.49K
1,806.39%2.25M
-80.06%5.2M
52,308.82%5.06M
Net cash flow
Beginning cash position
-38.66%5.93M
-39.69%6.76M
-41.97%6.75M
-41.15%11.63M
-5.90%8.13M
-15.66%9.67M
-25.84%11.21M
-41.15%11.63M
2,370.22%19.76M
-60.74%8.64M
Current changes in cash
113.05%218.2K
46.09%-827.05K
113.67%55.96K
42.38%-4.83M
-141.53%-1.22M
41.33%-1.67M
57.90%-1.53M
91.53%-409.36K
-144.78%-8.39M
222.36%2.94M
Effect of exchange rate changes
-69.64%39.61K
59.39%-2.17K
-500.01%-42.3K
-117.52%-45.35K
-417.62%-163.44K
467.93%130.47K
23.72%-5.33K
-103.68%-7.05K
15.66%258.82K
-66.21%51.46K
End cash Position
-23.86%6.19M
-38.66%5.93M
-39.69%6.76M
-41.97%6.75M
-41.97%6.75M
-5.90%8.13M
-15.66%9.67M
-25.84%11.21M
-41.15%11.63M
-41.15%11.63M
Free cash flow
114.55%240.16K
46.77%-805.09K
69.14%-822.09K
48.30%-7.02M
43.74%-1.2M
42.33%-1.65M
58.51%-1.51M
46.20%-2.66M
-85.63%-13.59M
10.92%-2.13M
Currency Unit
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 114.55%240.16K46.77%-805.09K69.14%-822.09K48.30%-7.02M43.74%-1.2M42.33%-1.65M58.51%-1.51M46.20%-2.66M-85.63%-13.59M10.92%-2.13M
Net income from continuing operations 115.77%229.9K72.00%-574.14K27.88%-1.68M50.74%-7.37M48.40%-1.53M45.14%-1.46M54.31%-2.05M51.93%-2.34M-72.99%-14.96M-3.28%-2.96M
Operating gains losses 69.64%-39.61K-59.39%2.17K500.01%42.3K117.52%45.35K417.62%163.44K-467.93%-130.47K-23.72%5.33K103.68%7.05K-15.66%-258.82K66.21%-51.46K
Depreciation and amortization 0.00%18.11K-0.01%18.11K0.01%18.11K1,100.10%72.45K200.02%18.11K--18.11K--18.11K--18.11K--6.04K--6.04K
Other non cash items -72.88%1.24K-60.14%2.13K-50.93%2.97K-32.88%19.75K74.23%3.79K--4.58K--5.33K--6.06K-92.02%29.42K--2.17K
Change In working capital 52.35%-153.43K-200.16%-479.99K168.74%579.85K-230.05%-941.72K-130.26%-255.36K35.77%-322K-11.94%479.25K-419.24%-843.6K136.58%724.13K233.34%843.75K
-Change in receivables 862.32%536.01K-2,061.29%-508.21K-108.35%-8.06K360.33%118.8K173.02%66.7K-162.80%-70.31K197.00%25.91K344.04%96.5K58.57%-45.63K-184.01%-91.34K
-Change in prepaid assets -215.89%-43K181.02%16.76K-169.82%-4.38K3,519.30%136.74K235.54%114.04K662.24%37.11K-136.29%-20.68K-75.93%6.27K104.20%3.78K-109.65%-84.14K
-Change in payables and accrued expense -123.84%-646.44K-97.58%11.46K162.58%592.29K-256.30%-1.2M-142.79%-436.1K53.28%-288.8K-7.76%474.02K-535.25%-946.38K51.34%765.99K213.21%1.02M
Cash from discontinued investing activities
Operating cash flow 114.55%240.16K46.77%-805.09K69.14%-822.09K48.30%-7.02M43.74%-1.2M42.33%-1.65M58.51%-1.51M46.20%-2.66M-85.63%-13.59M10.92%-2.13M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -2.18%-21.96K-2.17%-21.96K-61.05%878.04K-57.86%2.19M-100.43%-21.65K-279.08%-21.49K-1,376.13%-21.49K1,806.39%2.25M-80.06%5.2M52,308.82%5.06M
Net issuance payments of debt -2.18%-21.96K-2.17%-21.96K-2.18%-21.96K-1,102.35%-86.11K-187.14%-21.65K---21.49K32.84%-21.49K---21.49K---7.16K--24.84K
Net common stock issuance --0--0-26.08%900K-69.83%1.22M--0--0--0--1.22M-85.46%4.03M--4.03M
Proceeds from stock option exercised by employees --0--0--0-44.87%1.09M--0--0--0817.78%1.09M1,576.70%1.97M19,050.48%1.84M
Net other financing activities ------------96.63%-26.98K--0--0--0---26.98K55.72%-799.98K---833.66K
Cash from discontinued financing activities
Financing cash flow -2.18%-21.96K-2.17%-21.96K-61.05%878.04K-57.86%2.19M-100.43%-21.65K-279.08%-21.49K-1,376.13%-21.49K1,806.39%2.25M-80.06%5.2M52,308.82%5.06M
Net cash flow
Beginning cash position -38.66%5.93M-39.69%6.76M-41.97%6.75M-41.15%11.63M-5.90%8.13M-15.66%9.67M-25.84%11.21M-41.15%11.63M2,370.22%19.76M-60.74%8.64M
Current changes in cash 113.05%218.2K46.09%-827.05K113.67%55.96K42.38%-4.83M-141.53%-1.22M41.33%-1.67M57.90%-1.53M91.53%-409.36K-144.78%-8.39M222.36%2.94M
Effect of exchange rate changes -69.64%39.61K59.39%-2.17K-500.01%-42.3K-117.52%-45.35K-417.62%-163.44K467.93%130.47K23.72%-5.33K-103.68%-7.05K15.66%258.82K-66.21%51.46K
End cash Position -23.86%6.19M-38.66%5.93M-39.69%6.76M-41.97%6.75M-41.97%6.75M-5.90%8.13M-15.66%9.67M-25.84%11.21M-41.15%11.63M-41.15%11.63M
Free cash flow 114.55%240.16K46.77%-805.09K69.14%-822.09K48.30%-7.02M43.74%-1.2M42.33%-1.65M58.51%-1.51M46.20%-2.66M-85.63%-13.59M10.92%-2.13M
Currency Unit CADCADCADCADCADCADCADCADCADCAD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg